Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5211

Sort by

Sort Order Select

Journal Articles

Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era

Pontus Hedberg, Lisa Blixt, Sandra Eketorp Sylvan, Isabela Killander Möller, Hannes Lindahl, Fredrik Kahn, Åsa Nilsdotter-Augustinsson, Mats Fredrikson, Sofia Nyström, Peter Bergman, Christina Carlander, Soo Aleman, Pontus Nauclér, Anders Österborg, Lotta Hansson

Blood Adv (2025) 9 (13): 3170–3181.

https://doi.org/10.1182/bloodadvances.2024015260

Published: 2025

Includes: Supplemental data

Journal Articles

Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis

Azhwar Raghunath, Catherine E. Richter, Megan S. Griffin, Sylvia M. Emly, Murat Yaman, Valder R. Arruda, Benjamin J. Samelson-Jones, Jordan A. Shavit

Blood Adv (2025) 9 (13): 3136–3148.

https://doi.org/10.1182/bloodadvances.2024013143

Published: 2025

Includes: Supplemental data

Journal Articles

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury

E. Bridget Kim, Jack E. Malespini, Matthew Lei, Samuel S. Han, Cole W. Minsky, Andrew R. Branagan, Elizabeth K. O’Donnell, Diana Cirstea, Noopur S. Raje, Andrew J. Yee

Blood Adv (2025) 9 (13): 3129–3135.

https://doi.org/10.1182/bloodadvances.2025015901

Published: 2025

Includes: Supplemental data

Journal Articles

Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations

Suely Meireles Rezende, Ignacio Neumann, Benjamim Djulbegovic

Blood Adv (2025) 9 (13): 3182–3189.

https://doi.org/10.1182/bloodadvances.2025016102

Published: 2025

Includes: Supplemental data

Journal Articles

A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia

Mengyang Song, Xiaolei Wei, Hualei Luo, Jueheng Wang, Yuhua Ye, Lang Qin, Chao Niu, Yong Long, Xingmin Wang, Congwen Shao, Miao Yu, Feng Gu, Xinhua Zhang, Xiangmin Xu

Blood Adv (2025) 9 (13): 3159–3169.

https://doi.org/10.1182/bloodadvances.2024013695

Published: 2025

Includes: Supplemental data

Journal Articles

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Meira Yisraeli Salman, Alexander R. Terry, Andriy Derkach, David Nemirovsky, Kuo-Kai Chin, Yannis K. Valtis, Leora Boussi, Theresa Spivey, Wenbin Xiao, Christopher Famulare, Jenna Ciervo, Jacob M. Rowe, Martin S. Tallman, Eytan M. Stein

Blood Adv (2025) 9 (13): 3213–3222.

https://doi.org/10.1182/bloodadvances.2024015324

Published: 2025

Includes: Supplemental data

Journal Articles

Expression and treatment of ROR1 + cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia

Paraskevi Diamanti, Bethan K. Bailey, Obinna E. Iheanacho, John P. Moppett, Amit C. Nathwani, Allison Blair

Blood Adv (2025) 9 (13): 3190–3201.

https://doi.org/10.1182/bloodadvances.2024013814

Published: 2025

Includes: Supplemental data

Journal Articles

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

Yohei Doi, Takayuki Hamano, Osamu Yamaguchi, Yoshitaka Isaka

Blood Adv (2025) 9 (13): 3202–3212.

https://doi.org/10.1182/bloodadvances.2025016320

Published: 2025

Includes: Supplemental data

Journal Articles

COVID-19 and CLL in Sweden: lessons learned?

Stephen P. Mulligan

Blood Adv (2025) 9 (13): 3223–3225.

https://doi.org/10.1182/bloodadvances.2025016266

Published: 2025

Journal Articles

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution

Andreas Riedel, Laurent Phely, Stefan Hug, Philipp Faustmann, Jan Christian Schroeder, Britta Besemer, Anna M. Paczulla Stanger, Christoph Faul, Claudia Lengerke, Jan Frederic Weller, Wolfgang Bethge

Blood Adv (2025) 9 (13): 3149–3158.

https://doi.org/10.1182/bloodadvances.2024015346

Published: 2025

Includes: Supplemental data

Journal Articles

Younger haplo-donors improve older patient survival outcomes

Ahmad Ghorab, Leo Luznik

Blood Adv (2025) 9 (13): 3308–3309.

https://doi.org/10.1182/bloodadvances.2025016335

Published: 2025

Journal Articles

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Marek Trněný, Laura Fogliatto, Faithlore Gardner, Ian Flinn, Jean-François Larouche, Corinne Haioun, Miguel Canales, Hideki Goto, Roman Hajek, Gilles Salles, Avrita Singh, Mark Yan, Rucha Kothari, Gabriel Man, Deniz Sahin, Jamie Hirata, Calvin Lee, Hervé Tilly, Christopher R. Flowers

Blood Adv (2025) 9 (13): 3263–3267.

https://doi.org/10.1182/bloodadvances.2024014695

Published: 2025

Journal Articles

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Blood Adv (2025) 9 (13): 3238–3248.

https://doi.org/10.1182/bloodadvances.2024015494

Published: 2025

Journal Articles

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Blood Adv (2025) 9 (13): 3268–3280.

https://doi.org/10.1182/bloodadvances.2025015793

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation

Blood Adv (2025) 9 (13): 3226–3237.

https://doi.org/10.1182/bloodadvances.2024014938

Published: 2025

Includes: Supplemental data

Journal Articles

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma

Bo Zhang, Yaping Xie, Minmin Shen, Jianai Sun, Yue Li, Jing Zhang, Qi Li, Chuanghua Chen, Zhenzhen Chen, Wei Wang, Jingcheng Wu, Zhan Zhou, Jianhua Fang, Youyou Yan, Shenxian Qian, Xiangmin Tong, Nengming Lin, Hongyan Tong

Blood Adv (2025) 9 (13): 3249–3262.

https://doi.org/10.1182/bloodadvances.2024015469

Published: 2025

Includes: Supplemental data

Journal Articles

Complement C5 inhibition in early onset HELLP syndrome

Gloria F. Gerber, Robert A. Brodsky, Arthur Jason Vaught

Blood Adv (2025) 9 (13): 3304–3307.

https://doi.org/10.1182/bloodadvances.2024014746

Published: 2025

Includes: Supplemental data

Journal Articles

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies

Yang Li, Corinna Kosnopfel, Daniela Schwammbach, Ling Jin, Michael Grau, Georg Lenz, Stephan Hailfinger

Blood Adv (2025) 9 (13): 3310–3314.

https://doi.org/10.1182/bloodadvances.2025016199

Published: 2025

Includes: Supplemental data

Journal Articles

Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

Blood Adv (2025) 9 (13): 3293–3303.

https://doi.org/10.1182/bloodadvances.2025015855

Published: 2025

Includes: Supplemental data

Journal Articles

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

Blood Adv (2025) 9 (13): 3281–3292.

https://doi.org/10.1182/bloodadvances.2024015415

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era

Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury

Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations

A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Expression and treatment of ROR1 + cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia

Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females

COVID-19 and CLL in Sweden: lessons learned?

Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution

Younger haplo-donors improve older patient survival outcomes

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study

Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704

Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma

Complement C5 inhibition in early onset HELLP syndrome

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies

Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only